42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1243994
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => d4c66e00-dcd6-4e1c-b96c-3ed6218a1549
[Document ID] => 1243994
[Document naam] => FW: AstraZeneca: AZD1222 US Phase III primary analysis confirmssafety and efficacy
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1243994
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1243994
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
[DocumentPublicationDate] => 25 maart 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 08:09:03
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 08:09:03
)
Document: VWS-WOO-08-1243994
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210325
Geregistreerde documentnaam: FW: AstraZeneca: AZD1222 US Phase III primary analysis confirmssafety and efficacy
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 20:02:33 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 20:02:33 |
| DocumentDownload_linkname | Download (pdf, 937.08 KB) | 2025-07-10 19:53:09 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/document/1eec1b43-3629-6294-893e-bb3705657b16 | 2025-07-10 19:53:09 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1243994.pdf | 2025-07-10 19:53:09 |
| document_SectionDownloadButton | 1 | 2025-07-10 19:53:09 |
| document_SectionHistory | 1 | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over FW: AstraZeneca: AZD1222 US Phase III primary analysis confirmssafety and efficacy (documentnummer 1eec1b43-3629-6294-893e-bb3705657b16) | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:45:23 |
| document_SectionRequest | 1 | 2025-06-22 23:45:23 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 2021 | 2025-06-22 23:45:23 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo | 2025-06-22 23:45:23 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 2021 | 2025-06-22 23:45:23 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 23 november 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties & Medicatie maart 2021. | 2025-06-22 23:45:23 |
| Request_Periode | Maart 2021 | 2025-06-22 23:45:23 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:45:23 |
| Request_Datum besluit | 23 november 2023 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking | 15.961 documenten, 29.047 pagina's Inventarislijst | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_documenten | 15.961 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_paginas | 29.047 | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/inventory | 2025-06-22 23:45:23 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:45:23 |
| document_documentName | FW: AstraZeneca: AZD1222 US Phase III primary analysis confirmssafety and efficacy | 2025-06-22 23:45:23 |
| document_documentType | E-mailbericht | 2025-06-22 23:45:23 |
| document_documentPublicationDate | 2021-03-25 | 2025-06-22 23:45:23 |
| document_documentNumber | VWS-WOO-08-1243994 | 2025-06-22 23:45:23 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:45:23 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:45:23 |
| document_SectionAbout | 1 | 2025-06-22 23:45:23 |
| About_Datum document | 25 maart 2021 | 2025-06-22 23:45:23 |
| About_Type bronbestand | E-mailbericht, 2 pagina's | 2025-06-22 23:45:23 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:45:23 |
| About_Download als | PDF (937.08 KB) | 2025-06-22 23:45:23 |
| About_Documentnummer | 1243994 | 2025-06-22 23:45:23 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:45:23 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:45:23 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:45:23 |
| History Actie_2 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_3 | 30 mei 2024 18:34 | 2025-06-21 06:27:29 |
| History Actie_3 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_4 | 30 mei 2024 18:19 | 2025-06-21 06:27:29 |
| History Actie_4 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_5 | 30 mei 2024 16:48 | 2025-06-21 06:27:29 |
| History Actie_5 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_6 | 30 mei 2024 16:34 | 2025-06-21 06:27:29 |
| History Actie_6 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_7 | 30 mei 2024 15:01 | 2025-06-21 06:27:29 |
| History Actie_7 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_8 | 30 mei 2024 14:48 | 2025-06-21 06:27:29 |
| History Actie_8 | Bronbestand toegevoegd (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_2 | 30 mei 2024 19:10 | 2025-06-21 06:27:29 |
| History Actie_1 | Bronbestand vervangen (pdf, 937.08 KB) | 2025-06-21 06:27:29 |
| History Datum_1 | 30 mei 2024 19:16 | 2025-06-21 06:27:29 |
Archiefversies (6 rijen)
Archiefrij 1 — 2025-09-07 17:25:09
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1243994.pdf
documentName: VWS-WOO-08-1243994.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 959572
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:25:09
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:25:09
lastSeen: 2025-09-07 17:25:09
text: 1243994
To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl]
From: 5.1.2e lsizee5.1.2e
Sent: Thur 3/25/2021 7:24:50 AM
Subject: FW: AstraZeneca: AZD1222 USPhase Illprimary analysis confirmssafety and efficacy
Received:Thur 3/25/2021 7:24:51 AM5.1.2e
Ter info.
Groet,
Verzonden metBlac...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 85f8d6cbe99a455dc427eb299fc883792682a76d8ce2712c33753722f3b130ba
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: folder_import_44578_2ca04a8502e336b10df513318e87acbe
textDigestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1243994
Archiefrij 2 — 2025-09-04 17:12:23
fromFile: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
documentName: VWS-WOO-08-1243994.pdf
documentType: pdf
documentCompressedSize: 669246
documentSize: 959572
documentCompressRatio: 69.74421929777026
documentDateModified: 2025-05-01 20:39:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:12:23
lastSeen: 2025-09-04 17:12:23
text: 1243994 5.1.2e To: (IEE IEA 5.1.2e From: 1 @ (EE EEE @ inv minvws.nl] lsizee ni); BED, BE. 1B (ED dMERETM @minvws. ni] 5.1.2e Sent: Thur 3/25/2021 7:24:50 AM Subject: FW: AstraZeneca: AZD1222 US Phase Ill primary analysis confirmssafety and effic...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 85f8d6cbe99a455dc427eb299fc883792682a76d8ce2712c33753722f3b130ba
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip_3946
textDigestSHA256: 726846db1fdcb2a9c6f21d477edf35c88551cee35ae09eab1dd01d400d248582
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08-1243994
Archiefrij 3 — 2025-09-04 17:10:20
fromFile: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
documentName: VWS-WOO-08-1243994.pdf
documentType: pdf
documentCompressedSize: 669246
documentSize: 959572
documentCompressRatio: 69.74421929777026
documentDateModified: 2025-05-01 20:39:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:10:20
lastSeen: 2025-09-04 17:10:20
text: 1243994 5.1.2e To: (IEE IEA 5.1.2e From: 1 @ (EE EEE @ inv minvws.nl] lsizee ni); BED, BE. 1B (ED dMERETM @minvws. ni] 5.1.2e Sent: Thur 3/25/2021 7:24:50 AM Subject: FW: AstraZeneca: AZD1222 US Phase Ill primary analysis confirmssafety and effic...
noTextDate: leeg!
ocrText: isoweek-2021 isoweek-2022 |Ct-waarde 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 85f8d6cbe99a455dc427eb299fc883792682a76d8ce2712c33753722f3b130ba
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip_3946
textDigestSHA256: 726846db1fdcb2a9c6f21d477edf35c88551cee35ae09eab1dd01d400d248582
ocrTextDigestSHA256: 34ea7743594f08b217c2e155c1f4035ef17e172d69327d310aa73507055b967b
extractedId: VWS-WOO-08-1243994
Archiefrij 4 — 2025-03-18 09:30:26
fromFile: 2024.075-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1243994-FW_AstraZeneca_AZD1222_US_Phase_III_primary_analysis_confirmssafety_and_efficacy.pdf
documentType: pdf
documentCompressedSize: 667747
documentSize: 959572
documentCompressRatio: 69.58800381836903
documentDateModified: 2024-10-25 13:30:02
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1243994
To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl]
From: 5.1.2e lsizee5.1.2e
Sent: Thur 3/25/2021 7:24:50 AM
Subject: FW: AstraZeneca: AZD1222 USPhase Illprimary analysis confirmssafety and efficacy
Received:Thur 3/25/2021 7:24:51 AM5.1.2e
Ter info.
Groet,
Verzonden metBlac...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 354985
textDigestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1243994
Archiefrij 5 — 2025-02-27 09:25:06
fromFile: 2022.252-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2022.252-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1243994-FW_AstraZeneca_AZD1222_US_Phase_III_primary_analysis_confirmssafety_and_efficacy.pdf
documentType: pdf
documentCompressedSize: 667747
documentSize: 959572
documentCompressRatio: 69.58800381836903
documentDateModified: 2024-10-25 13:30:02
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1243994
To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl]
From: 5.1.2e lsizee5.1.2e
Sent: Thur 3/25/2021 7:24:50 AM
Subject: FW: AstraZeneca: AZD1222 USPhase Illprimary analysis confirmssafety and efficacy
Received:Thur 3/25/2021 7:24:51 AM5.1.2e
Ter info.
Groet,
Verzonden metBlac...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 37, "email": "EDdMERETM@minvws.ni", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e"}, {"position": 65, "email": "@minvws.nl", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e lsizee5.1.2e"}]
documentMailAdresses: [{"position": 37, "email": "EDdMERETM@minvws.ni", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e"}, {"position": 65, "email": "@minvws.nl", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e lsizee5.1.2e"}]
digestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 268155
textDigestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1243994
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
documentName: VWS-WOO-08-1243994-FW_AstraZeneca_AZD1222_US_Phase_III_primary_analysis_confirmssafety_and_efficacy.pdf
documentType: pdf
documentCompressedSize: 667747
documentSize: 959572
documentCompressRatio: 69.58800381836903
documentDateModified: 2024-10-25 13:30:02
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1243994
To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl]
From: 5.1.2e lsizee5.1.2e
Sent: Thur 3/25/2021 7:24:50 AM
Subject: FW: AstraZeneca: AZD1222 USPhase Illprimary analysis confirmssafety and efficacy
Received:Thur 3/25/2021 7:24:51 AM5.1.2e
Ter info.
Groet,
Verzonden metBlac...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 37, "email": "EDdMERETM@minvws.ni", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e"}, {"position": 65, "email": "@minvws.nl", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e lsizee5.1.2e"}]
documentMailAdresses: [{"position": 37, "email": "EDdMERETM@minvws.ni", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e"}, {"position": 65, "email": "@minvws.nl", "context": "1243994 To:1(EEEEE@inv ni);BED,BE.1B(EDdMERETM@minvws.ni](IEEIEA @minvws.nl] From: 5.1.2e lsizee5.1.2e"}]
digestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 57291
textDigestSHA256: cacccf25877716752dd878dcf97c62388037c07af6be637f16e761538102e95c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1243994
(dit is ook een speeltuin)